12
Paraganglioma Treatment Market Research Report conducts a deep estimation of the present state of the Paraganglioma Treatment Industry with the definition, classification, and market scope. The data included in the report has been generated by consulting industry leaders and taking inputs from them. The topmost subdivisions of the market have been emphasized and these divisions have been presented by giving statistics on their current state by the end of the forecast horizon.
Paraganglioma Treatment Market Insight:
Global Paraganglioma Treatment Market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Presence of refined healthcare infrastructure and increase in special designation from the regulatory authorities are the key factors that drive the market
6
Imaging Tracers Market Research Report conducts a deep estimation of the present state of the Imaging Tracers Industry with the definition, classification, and market scope. The data included in the report has been generated by consulting industry leaders and taking inputs from them. The topmost subdivisions of the market have been emphasized and these divisions have been presented by giving statistics on their current state by the end of the forecast horizon.
Imaging Tracers Market Insight:
Global Imaging Tracers Market is expected to grow with a steady CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018, and the historic year of 2017. This rise in market value can be attributed to increase in applications of diagnostic devices and equipments due to the rising prevalence of geriatric population and chronic diseases.
Pheochromocytoma Market Growth and key Industry Players 2018 Analysis and Forecasts to 2025 texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Columbia Daily Tribune
Under a new agreement, the University of Missouri Research Reactor will supply a radioisotope that serves as a key ingredient in a cancer therapy.
The multi-year agreement is with Advanced Accelerator Applications International, a Novartis pharmaceutical manufacturing company.
Since 2017, the research reactor has produced the radioisotope Lutetium-177 for the company under the name Lutathera. It is used to treat some tumors of the gastrointestinal tract and pancreas.
The new version of the radioisotope contains no trace of the long-lived isotope. That s a real benefit because hospitals won t have the same regulations for use, storage and disposal they have with the current version, said David Robertson, research reactor director.
Advanced Accelerator Applications Major Investment in Indiana insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.